Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women – MarketWatch

September 17, 2014 10:53 am

http://www.marketwatch.com/story/novavax-initiates-phase-2-clinical-trial-of-rsv-f-protein-nanoparticle-vaccine-candidate-in-healthy-third-trimester-pregnant-women-2014-09-16

Leave a Reply

Your email address will not be published. Required fields are marked *


*

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now